tDCS + CIMT for Cerebral Palsy
Trial Summary
Do I need to stop my current medications for the trial?
Yes, you will need to stop taking any psychoactive or muscle-relaxing medications during the study.
What data supports the effectiveness of the treatment tDCS for cerebral palsy?
Research shows that transcranial direct current stimulation (tDCS) is safe and can improve hand function in children with cerebral palsy, especially when combined with other therapies like constraint-induced movement therapy (CIMT). However, the specific effect of tDCS alone on improving motor function is not yet clear, and more studies are needed to determine the best way to use it.12345
Is transcranial direct current stimulation (tDCS) safe for people with cerebral palsy?
How is the treatment tDCS + CIMT for cerebral palsy different from other treatments?
The treatment combines transcranial direct current stimulation (tDCS), which uses a mild electrical current to stimulate the brain, with constraint-induced movement therapy (CIMT), which encourages the use of the affected limb by restricting the unaffected one. This combination aims to enhance motor function by potentially reorganizing brain pathways, making it a novel approach compared to traditional therapies that do not use electrical brain stimulation.12345
What is the purpose of this trial?
This study aims to test if transcranial direct current stimulation (tDCS) can be applied to boost the efficacy of constraint-induced movement therapy (CIMT) in children with HCP and examine brain mechanisms related to individual outcomes.
Research Team
Yanlong Song, PhD
Principal Investigator
University of Texas Southwestern Medical Center
Eligibility Criteria
This trial is for children with Hemiplegic Cerebral Palsy (HCP), a condition affecting one side of the body. Participants should be able to follow instructions and attend multiple therapy sessions. Children with metal in their head, skin conditions on the scalp, seizures, or those who can't tolerate having their stronger arm restrained are excluded.Inclusion Criteria
Exclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Intervention
Participants receive either anodal tDCS and CIMT or sham tDCS and CIMT for 2 hours, five days a week
Follow-up
Participants are monitored for safety and effectiveness after treatment
Treatment Details
Interventions
- tDCS
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of Texas Southwestern Medical Center
Lead Sponsor
Children's Health
Collaborator